+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity



Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity



Mitochondrion 10(2): 115-124



Ethambutol (EMB), widely used in the treatment of tuberculosis, has been reported to cause Leber's hereditary optic neuropathy in patients carrying mitochondrial DNA mutations. We study the effect of EMB on mitochondrial metabolism in fibroblasts from controls and from a man carrying an OPA1 mutation, in whom the drug induced the development of autosomal dominant optic atrophy (ADOA). EMB produced a mitochondrial coupling defect together with a 25% reduction in complex IV activity. EMB induced the formation of vacuoles associated with decreased mitochondrial membrane potential and increased fragmentation of the mitochondrial network. Mitochondrial genetic variations may therefore be predisposing factors in EMB-induced ocular injury.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053044630

Download citation: RISBibTeXText

PMID: 19900585

DOI: 10.1016/j.mito.2009.11.004


Related references

Ethambutol-induced optic neuropathy and the 15257 mitochondrial DNA mutation. Investigative Ophthalmology & Visual Science 36(4): S1060, 1995

A case of ethambutol-induced optic neuropathy harbouring the primary mitochondrial LHON mutation at nt 11778. Journal Of Neurology. 245(5): 299-302,, 1998

Ethambutol optic neuropathy and the 15257 mitochondrial DNA mutation. Neurology 45(4 Suppl. 4): A369, 1995

A murine model of transitory optic neuropathy based on small interference RNA-induced OPA1 silencing in vivo (gene mutation associated with Kjer's disease). Journal Francais d'Ophtalmologie 29(8): 875-880, 2006

The role of copper on mitochondrial metabolism in patients with ethambutol-induced toxic optic neuropathy and in mycobacterial infection. Investigative Ophthalmology & Visual Science 38(4 Part 1-2): S147, 1997

Leber's hereditary optic neuropathy masquerading as ethambutol-induced optic neuropathy in a young male. Indian Journal of Ophthalmology 54(3): 218-219, 2006

Reversible optic neuropathy with OPA1 exon 5b mutation. Annals of Neurology 63(5): 667-671, 2008

The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy. Diagnostic Microbiology and Infectious Disease 30(2): 83-87, 1998

Leber's hereditary optic neuropathy mutations in ethambutol-induced optic neuropathy. Journal of Neurology 250(1): 87-89, 2003

A Thai patient with Leber's hereditary optic neuropathy linked to mitochondrial DNA 14484 mutation. Southeast Asian Journal of Tropical Medicine & Public Health 35(1): 167-168, 2004

Dysregulated mitophagy and mitochondrial transport in sensori-motor neuropathy due to Dominant Optic Atrophy plus with OPA1 (Optic Atrophy 1) mutations. Neuromuscular Disorders 25: S185-S186, 2015

Case report: A Thai patient with Leber's hereditary optic neuropathy linked to mitochondrial DNA 14484 mutation. Southeast Asian Journal of Tropical Medicine and Public Health 35(1): 167-168, 2004

Optic nerve neuropathy by ethambutol toxicity. Zhonghua Jie he He Hu Xi Za Zhi 22(5): 302-304, 1999

Mitochondrial disorder with OPA1 mutation lacking optic atrophy. Mitochondrion 9(4): 279-281, 2009

Diagnostic genetic testing for patients with bilateral optic neuropathy and comparison of clinical features according to OPA1 mutation status. Molecular Vision 23: 548-560, 2017